OpenURL Connection Search

Select item for more details and to access through your institution.

Low mutation rate of hMSH2 and hMLH1 in Taiwanese hereditary non-polyposis colorectal cancer.
Published in:
Clinical Genetics, 2003, v. 64, n. 3, p. 243, doi. 10.1034/j.1399-0004.2003.00123.x
By:
- S-C Wei, E.;
- C-Y Yu, E.;
- J-J Tsai-Wu, E.;
- Y-N Su, E.;
- J-C Sheu, E.;
- C-HH Wu, E.;
- C-Y Wang, E.;
- J-M Wong, E.
Publication type:
Article
Hypertriglyceridaemic–waist phenotype and risk of diabetes in people with impaired fasting glucose in primary care: a cohort study.
Published in:
Diabetic Medicine, 2018, v. 35, n. 5, p. 576, doi. 10.1111/dme.13601
By:
- Guo, V. Y.‐W.;
- Yu, E. Y.‐T.;
- Wong, C. K.‐H.;
- Sit, R. W.‐S.;
- Wang, J. H.‐L.;
- Lam, C. L.‐K.
Publication type:
Article
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy.
Published in:
World Journal of Urology, 2019, v. 37, n. 1, p. 165, doi. 10.1007/s00345-018-2361-0
By:
- Vasdev, N.;
- Zargar, H.;
- Noël, J. P.;
- Veeratterapillay, R.;
- Fairey, A. S.;
- Mertens, L. S.;
- Dinney, C. P.;
- Mir, M. C.;
- Krabbe, L. M.;
- Cookson, M. S.;
- Jacobsen, N. E.;
- Gandhi, N. M.;
- Griffin, J.;
- Montgomery, J. S.;
- Yu, E. Y.;
- Xylinas, E.;
- Campain, N. J.;
- Kassouf, W.;
- Dall'Era, M. A.;
- Seah, J. A.
Publication type:
Article
Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis.
Published in:
2009
By:
- Koreckij, T.;
- Nguyen, H.;
- Brown, L. G.;
- Yu, E. Y.;
- Vessella, R. L.;
- Corey, E.
Publication type:
journal article
Activity of enzamtamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel.
Published in:
Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 2, p. 122, doi. 10.1038/pcan.2014.53
By:
- Cheng, H. H.;
- Gulati, R.;
- Azad, A.;
- Nadal, R.;
- Twardowski, P.;
- Vaishampayan, U. N.;
- Agarwal, N.;
- Heath, E. I.;
- Pal, S. K.;
- Rehman, H.-t.;
- Leiter, A.;
- Batten, J. A.;
- Montgomery, R. B.;
- Galsky, M. D.;
- Antonarakis, E. S.;
- Chi, K. N.;
- Yu, E. Y.
Publication type:
Article
The relation of p53 protein nuclear accumulation and angiogenesis in human prostatic carcinoma.
Published in:
Prostate Cancer & Prostatic Diseases, 1997, v. 1, n. 1, p. 39, doi. 10.1038/sj.pcan.4500205
By:
- Yu, E Y;
- Yu, E;
- Meyer, G E;
- Brawer, M K
Publication type:
Article
Remifentanil tolerance and hyperalgesia: short-term gain, long-term pain?
Published in:
2016
By:
- Yu, E. H. Y.;
- Tran, D. H. D.;
- Lam, S. W.;
- Irwin, M. G.
Publication type:
journal article

Found: 7

Low mutation rate of hMSH2 and hMLH1 in Taiwanese hereditary non-polyposis colorectal cancer.

Hypertriglyceridaemic–waist phenotype and risk of diabetes in people with impaired fasting glucose in primary care: a cohort study.

Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy.

Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis.

Activity of enzamtamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel.

The relation of p53 protein nuclear accumulation and angiogenesis in human prostatic carcinoma.

Remifentanil tolerance and hyperalgesia: short-term gain, long-term pain?